Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Geriatric assessment-driven intervention (GAIN) on chemotherapy toxicity in older adults

Daneng Li • 4 Jul 2020
ASCO 2020
Gastrointestinal Cancer General

Daneng Li, MD, of City of Hope National Medical Center, Duarte, CA, outlines a randomized control trial evaluating geriatric assessment-driven intervention (GAIN) on chemotherapy toxicity in older adults with cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Daneng Li

4:05
Updates from IMbrave 150 in HCC
Daneng Li • 3 Jul 2020
3:56
Novel developments in HCC treatment
Daneng Li • 6 Jul 2020

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals